Loan A, Awaja N, Lui M, Syal C, Sun Y, Sarma S
Theranostics. 2024; 14(16):6110-6137.
PMID: 39431007
PMC: 11488099.
DOI: 10.7150/thno.97165.
Jinton H, Rotter Sopasakis V, Sjolin L, Oldfors A, Jeppsson A, Oras J
Sci Rep. 2024; 14(1):14256.
PMID: 38902373
PMC: 11190235.
DOI: 10.1038/s41598-024-65212-z.
Massoud D, Abd-Elhafeez H, Emeish W, Fouda M, Shaldoum F, Alrashdi B
BMC Vet Res. 2024; 20(1):73.
PMID: 38402164
PMC: 10893627.
DOI: 10.1186/s12917-024-03916-0.
Tapparo M, Saccu G, Pasquino C, Fonsato V, Medana C, Schiavo V
Front Cell Dev Biol. 2024; 12:1352013.
PMID: 38389704
PMC: 10881830.
DOI: 10.3389/fcell.2024.1352013.
Bustamante-Marin X, Capel B
Front Genet. 2023; 14:1179256.
PMID: 37180974
PMC: 10169730.
DOI: 10.3389/fgene.2023.1179256.
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions.
Chen Z, Han F, Du Y, Shi H, Zhou W
Signal Transduct Target Ther. 2023; 8(1):70.
PMID: 36797231
PMC: 9935926.
DOI: 10.1038/s41392-023-01332-8.
Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine.
Nowak-Stepniowska A, Osuchowska P, Fiedorowicz H, Trafny E
Stem Cells Int. 2022; 2022:8775591.
PMID: 35378955
PMC: 8976669.
DOI: 10.1155/2022/8775591.
The Role of Nitric Oxide in Stem Cell Biology.
Caballano-Infantes E, Cahuana G, Bedoya F, Salguero-Aranda C, Tejedo J
Antioxidants (Basel). 2022; 11(3).
PMID: 35326146
PMC: 8944807.
DOI: 10.3390/antiox11030497.
Tumour Microenvironment Stress Promotes the Development of Drug Resistance.
Seebacher N, Krchniakova M, Stacy A, Skoda J, Jansson P
Antioxidants (Basel). 2021; 10(11).
PMID: 34829672
PMC: 8615091.
DOI: 10.3390/antiox10111801.
Environmental Alterations during Embryonic Development: Studying the Impact of Stressors on Pluripotent Stem Cell-Derived Cardiomyocytes.
Lamberto F, Peral-Sanchez I, Muenthaisong S, Zana M, Willaime-Morawek S, Dinnyes A
Genes (Basel). 2021; 12(10).
PMID: 34680959
PMC: 8536136.
DOI: 10.3390/genes12101564.
Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance.
Tuy K, Rickenbacker L, Hjelmeland A
Redox Biol. 2021; 44:101953.
PMID: 34052208
PMC: 8212140.
DOI: 10.1016/j.redox.2021.101953.
DNMT3B Is an Oxygen-Sensitive De Novo Methylase in Human Mesenchymal Stem Cells.
Dogan F, Aljumaily R, Kitchen M, Forsyth N
Cells. 2021; 10(5).
PMID: 33925659
PMC: 8145390.
DOI: 10.3390/cells10051032.
An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells.
Lyra-Leite D, Fonoudi H, Gharib M, Burridge P
STAR Protoc. 2021; 2(1):100213.
PMID: 33786455
PMC: 7988236.
DOI: 10.1016/j.xpro.2020.100213.
Hypoxia in Cell Reprogramming and the Epigenetic Regulations.
Nakamura N, Shi X, Darabi R, Li Y
Front Cell Dev Biol. 2021; 9:609984.
PMID: 33585477
PMC: 7876330.
DOI: 10.3389/fcell.2021.609984.
Both Hypoxia-Inducible Factor 1 and MAPK Signaling Pathway Attenuate PI3K/AKT via Suppression of Reactive Oxygen Species in Human Pluripotent Stem Cells.
Fojtik P, Beckerova D, Holomkova K, Senfluk M, Rotrekl V
Front Cell Dev Biol. 2021; 8:607444.
PMID: 33553145
PMC: 7859355.
DOI: 10.3389/fcell.2020.607444.
In Vitro Induction of Pluripotency from Equine Fibroblasts in 20% or 5% Oxygen.
de Castro R, Pieri N, Fantinato Neto P, Grizendi B, Doria R, Meirelles F
Stem Cells Int. 2021; 2020:8814989.
PMID: 33456472
PMC: 7785345.
DOI: 10.1155/2020/8814989.
Induced Pluripotent Stem Cells on a Chip: A Self-Contained, Accessible, Pipette-less iPSC Culturing and Differentiation Kit.
McMinn P, Guckenberger D, Beebe D
SLAS Technol. 2020; 26(1):80-91.
PMID: 32552316
PMC: 10843275.
DOI: 10.1177/2472630320921173.
Energy Metabolism Regulates Stem Cell Pluripotency.
Tsogtbaatar E, Landin C, Minter-Dykhouse K, Folmes C
Front Cell Dev Biol. 2020; 8:87.
PMID: 32181250
PMC: 7059177.
DOI: 10.3389/fcell.2020.00087.
EMT signaling: potential contribution of CRISPR/Cas gene editing.
Mohammadinejad R, Biagioni A, Arunkumar G, Shapiro R, Chang K, Sedeeq M
Cell Mol Life Sci. 2020; 77(14):2701-2722.
PMID: 32008085
PMC: 11104910.
DOI: 10.1007/s00018-020-03449-3.
Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.
Steichen C, Hannoun Z, Luce E, Hauet T, Dubart-Kupperschmitt A
World J Stem Cells. 2019; 11(10):729-747.
PMID: 31692979
PMC: 6828592.
DOI: 10.4252/wjsc.v11.i10.729.